Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

560 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time to redefine Myeloma.
Pratt G, Bowcock S, Chantry A, Cook G, Jackson G, Lai M, Low E, Mulholland N, Owen R, Rabin N, Ramasamy K, Snowden JA, Streetly M, Wechalekar A, Yong K, Bird J. Pratt G, et al. Among authors: ramasamy k. Br J Haematol. 2015 Oct;171(1):1-10. doi: 10.1111/bjh.13620. Epub 2015 Jul 27. Br J Haematol. 2015. PMID: 26221971 Free article.
Mott cells in CD20-positive myeloma.
Ramasamy K, Ladon D, Salisbury J, Ireland R. Ramasamy K, et al. Br J Haematol. 2011 Feb;152(4):366. doi: 10.1111/j.1365-2141.2010.08508.x. Epub 2011 Jan 7. Br J Haematol. 2011. PMID: 21265822 Free article. No abstract available.
Pomalidomide therapy for myeloma.
Schey S, Ramasamy K. Schey S, et al. Among authors: ramasamy k. Expert Opin Investig Drugs. 2011 May;20(5):691-700. doi: 10.1517/13543784.2011.567265. Epub 2011 Mar 18. Expert Opin Investig Drugs. 2011. PMID: 21413906 Review.
Managing multiple myeloma in the over 70s: a review.
King AJ, Gooding S, Ramasamy K. King AJ, et al. Among authors: ramasamy k. Maturitas. 2015 Feb;80(2):148-54. doi: 10.1016/j.maturitas.2014.11.017. Epub 2014 Dec 2. Maturitas. 2015. PMID: 25541475 Review.
Optimizing the management of patients with spinal myeloma disease.
Molloy S, Lai M, Pratt G, Ramasamy K, Wilson D, Quraishi N, Auger M, Cumming D, Punekar M, Quinn M, Ademonkun D, Willis F, Tighe J, Cook G, Stirling A, Bishop T, Williams C, Boszczyk B, Reynolds J, Grainger M, Craig N, Hamilton A, Chalmers I, Ahmedzai S, Selvadurai S, Low E, Kyriakou C; UK Spinal Myeloma Working Group. Molloy S, et al. Among authors: ramasamy k. Br J Haematol. 2015 Nov;171(3):332-43. doi: 10.1111/bjh.13577. Epub 2015 Jul 17. Br J Haematol. 2015. PMID: 26184699 Free article.
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C, Rimashevskaya E, Pika T, Gaidano G, Weisel K, Goranova-Marinova V, Schwarer A, Minuk L, Masszi T, Karamanesht I, Offidani M, Hungria V, Spencer A, Orlowski RZ, Gillenwater HH, Mohamed N, Feng S, Chng WJ; ENDEAVOR Investigators. Dimopoulos MA, et al. Lancet Oncol. 2016 Jan;17(1):27-38. doi: 10.1016/S1470-2045(15)00464-7. Epub 2015 Dec 5. Lancet Oncol. 2016. PMID: 26671818 Free article. Clinical Trial.
560 results